Is Journey Medical Corp (NASDAQ: DERM) Stock Worth Investing In for High Returns?


In the last trading session, 69211.0 Journey Medical Corp (NASDAQ:DERM) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $5.38 changed hands at -$0.19 or -3.41% during last session, the market valuation stood at $107.65M. DERM’s last price was a discount, traded about -50.74% off its 52-week high of $8.11. The share price had its 52-week low at $1.52, which suggests the last value was 71.75% up since then. When we look at Journey Medical Corp’s average trading volume, we note the 3-month average coming to 142.65K.

Journey Medical Corp (NASDAQ:DERM) trade information

Instantly DERM was in red as seen at the end of in last trading. With action -5.28%, the performance over the past five days has been red. The drop to weekly highs of 6.15 subtracted -3.41% to the stock’s daily price. The company’s shares are showing year-to-date downside of -6.60%, with the 5-day performance at -5.28% in the red. However, in the 30-day time frame, Journey Medical Corp (NASDAQ:DERM) is 55.94% up.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Journey Medical Corp (DERM) estimates and forecasts

Data shows that the Journey Medical Corp share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -20.06% over the past 6 months, a -385.71% in annual growth rate that is considerably lower than the industry average of 13.50%.

The 2024 estimates are for Journey Medical Corp earnings to decrease by -345.24%.

DERM Dividends

Journey Medical Corp is expected to release its next quarterly earnings report in July.